Stock Comparison
TEVA vs UTHR
Teva Pharma Industries Ltd ADR and United Therapeutics Corporation side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$38.67B
$23.03B
P/E (TTM)
24.8
20.1
Forward P/E
16.0
19.8
Price/Sales
2.2
7.3
Price/Book
4.7
3.9
EV/EBITDA
16.3
11.6
Dividend Yield
—
—
Profitability
Net Margin
9.02%
40.60%
Operating Margin
19.20%
41.70%
Return on Equity
21.60%
20.30%
Return on Assets
6.38%
12.60%
Growth (YoY)
Revenue Growth
2.30%
-1.60%
Earnings Growth
72.20%
-12.20%
Price & Risk
Beta
0.9
0.6
52-Week High
$37.35
$609.35
52-Week Low
$14.99
$272.12
Analyst Target
$40.90
$665.23
Compare TEVA and UTHR your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.